Mersana Therapeutics GAAP EPS of -$1.51 misses by $0.30, revenue of $11M misses by $4.5M (NASDAQ:MRSN)
梅莎娜制药(US:MRSN) Seeking Alpha·2025-11-14 20:06To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...